Publication:
Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide

dc.contributor.authorsHaznedar, S; Dortunc, B
dc.date.accessioned2022-03-12T17:16:41Z
dc.date.accessioned2026-01-11T11:14:10Z
dc.date.available2022-03-12T17:16:41Z
dc.date.issued2004
dc.description.abstractThe aim of this study was to prepare and evaluate Eudragit (RS and RL) microspheres containing acetazolamide. Microspheres were prepared by solvent evaporation method using acetone/liquid paraffin system. The influence of formulation factors (stirring speed, polymer:drug ratio, type of polymer, ratio of the combination of polymers) on particle size, encapsulation efficiency and in vitro release characteristics of the microspheres were investigated. The yields of preparation and the encapsulation efficiencies were high for all formulations the microspheres were obtained. Mean particle size changed by changing the polymer:drug ratio or the stirring speed of the system. Although acetazolamide release rates from Eudragit RS microspheres were very slow and incomplete for all formulations, they were fast from Eudragit RL microspheres. When Eudragit RS was added to Eudragit RL microsphere formulations, release rates slowed down and achieved the release profile suitable for peroral administration. (C) 2003 Elsevier B.V All rights reserved.
dc.identifier.doi10.1016/j.ijpharm.2003.09.015
dc.identifier.eissn1873-3476
dc.identifier.issn0378-5173
dc.identifier.pubmed14698584
dc.identifier.urihttps://hdl.handle.net/11424/227658
dc.identifier.wosWOS:000188509200014
dc.language.isoeng
dc.publisherELSEVIER
dc.relation.ispartofINTERNATIONAL JOURNAL OF PHARMACEUTICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectacetazolamide
dc.subjectEudragit
dc.subjectmicrospheres
dc.subjectcontrolled release
dc.subjectRELEASE
dc.subjectMICROCAPSULES
dc.subjectDESIGN
dc.titlePreparation and in vitro evaluation of Eudragit microspheres containing acetazolamide
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage140
oaire.citation.issue1
oaire.citation.startPage131
oaire.citation.titleINTERNATIONAL JOURNAL OF PHARMACEUTICS
oaire.citation.volume269

Files